Airsonett

Ängelholm, Sweden

Airsonett is a research-based medical technology company that develops non-pharmaceutical treatment for allergic asthma.

$2.0M raised

Jul 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Airsonett raised?

Airsonett has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2022.

Who are Airsonett's investors?

Airsonett's investors include Industrifonden, Fåhraeus Startup and Growth, SEB Venture Capital.

Where is Airsonett headquartered?

Airsonett is headquartered in Ängelholm, Sweden.

What does Airsonett do?

Airsonett is a research-based medical technology company that develops non-pharmaceutical treatment for allergic asthma.

What stage is Airsonett at?

Airsonett is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 30, 2022.

MLA

"Airsonett — Funding & Investors." VCBacked, July 30, 2022, https://www.vcbacked.co/company/airsonett. Accessed July 2, 2026.

APA

VCBacked. (2022). Airsonett — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/airsonett

Wikipedia (cite web)

{{cite web |title=Airsonett — Funding & Investors |url=https://www.vcbacked.co/company/airsonett |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 30, 2022.